Business of Cannabis North America
FDA Approves Clinical Trial Into Cannabis as a Treatment for PTSD Following a 3-Year Block
The US Food and Drug Administration (FDA) has finally approved a Phase 2 clinical trial into cannabis in treatment of post-traumatic stress disorder (PTSD), three years after being put on hold.Â
Ben Stevens
November 22, 2024
